Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: A survey of 1182 north American laboratories

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 2, 2005, Pages 190-193

  Osby, Melanie ^a,b   Shulman, Ira A ^a  

^a Los Angeles Co Univ S CA Med C   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ABO ANTIGEN; BLOOD GROUP ANTIGEN; BLOOD GROUP C ANTIGEN; BLOOD GROUP E ANTIGEN; ERYTHROCYTE ANTIGEN; K ANTIGEN; RHESUS D ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ANTIGEN EXPRESSION; BLOOD GROUP; BLOOD GROUP ABO SYSTEM; CLINICAL PRACTICE; COLLEGE; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; DONOR; EDUCATION; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HEALTH SERVICE; HEALTH SURVEY; HOSPITAL; HUMAN; LABORATORY; LABORATORY TEST; MEDICAL INFORMATION; PATIENT; PERFORMANCE; PHENOTYPE; PROPHYLAXIS; SICKLE CELL ANEMIA;

ABO BLOOD-GROUP SYSTEM; ANEMIA, SICKLE CELL; BLOOD BANKS; BLOOD DONORS; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; DATA COLLECTION; ERYTHROCYTES; HUMANS; NORTH AMERICA; PHENOTYPE; RH-HR BLOOD-GROUP SYSTEM;

EID: 13444271906     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. National Institutes of Health, National Heart, Lung, and Blood Institute. Facts About Sickle Cell Anemia. Washington, DC: National Institutes of Health; 1996. NIH publication 96-4057.
2. Claster S, Vichinsky EP. Clinical review: managing sickle cell disease. BMJ. 2003;327:1151-1155.
3. National Institutes of Health, National Heart, Lung, and Blood Institute. Management of Sickle Cell Disease. 4th ed. Washington, DC: National Institutes of Health; 2002. NIH publication 02-2117.
4. Vichinsky EP, Luban N, Wright E, Olivieri N. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001;41:1086-1092.
5. Vichinsky EP, Earles A, Johnson RA, Hoag MS. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322:1617-1621.
6. Rosse WF, Gallagher D, Kinney TR, Castro O, for The Cooperative Study of Sickle Cell Disease. Transfusion and alloimmunization in sickle cell disease. Blood. 1990;76:1431-1437.
7. Davies SC, McWilliam AC, Hewitt PE, Devenish A, Brozovic M. Red cell alloimmunization in sickle cell disease. Br J Haematol. 1986;63:241-245.
8. Orlina AR, Unger PJ, Koshy M. Post-transfusion alloimmunization in patients with sickle cell disease. Am J Hematol. 1978;5:101-106.
9. Ness PM. To match or not to match: the question for chronically transfused patients with sickle cell anemia. Transfusion. 1994;34:558-560.
10. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion. 2002;42:684-690.
11. Afenyi-Annan A, Brecher ME. Pre-transfusion phenotype matching for sickle cell disease patients. Transfusion. 2004;44:619-620.
12. Wayne AS, Schoenike SE, Pegelow CH. Financial analysis of chronic transfusion for stroke prevention in sickle cell disease. Blood. 2000;96:2369-2372.